Multicenter, Double-blind, Randomized, Parallel-group, Monotherapy, Active-control Study to Determine the Efficacy and Safety of Daclizumab High Yield Process (DAC HYP) versus Avonex® (Interferon β-1a) in Patients with Relapsing-Remitting Multiple Sclerosis
Not yet posted. In progress. Plenty of Doom and Gloom (for me).
![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
zaluzianskya and ![[community profile]](https://www.dreamwidth.org/img/silk/identity/community.png)
skylark_photos
no subject
Date: 2014-06-25 05:01 pm (UTC)Not yet posted. In progress. Plenty of Doom and Gloom (for me).